Texas Health Presbyterian Hospital Dallas is dedicated to cancer research aimed at achieving advances in medicine and bringing innovative therapies to patients. Our researchers work to understand the disease, identify potential treatments or preventive therapies and establish the best care for patients. In 2011 and 2012, greater than 5 percent of our patients were treated through one of over 80 open clinical studies, many of which were conducted through our collaboration with US Oncology.
Nationally recognized for a commitment to cancer research, Texas Health Dallas was one of only 20 hospitals nationwide selected to participate in The Cancer Genome Atlas, sponsored by the National Cancer Institute. This project, which aims to create the most detailed information to date of the genes that control cancer cells, is a successor to the Human Genome Project that produced the first complete sequence of human DNA.
Physicans on the medical staff at Texas Health Dallas have been involved in a number of investigational studies resulting in the multiple publications, abstracts and national presentations, in the past year.